MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Approaches to understanding the role of STN in the development of ICD in Parkinson’s disease

    A. Buniak, V. Bayarchyk, A. Mikitchuk (Minsk, Belarus)

    Objective: The aim of this study was to identify the features of subthalamic tracts in PD patients with ICD. Background: Recurrent negative feedback loops from…
  • 2025 International Congress

    Poor sleep quality is one of the causes of cognitive decline in Parkinson’s disease (PD)-1

    K. Hasegawa, M. Miyashita, M. Sagawa, A. Kawanami (Kanagawa, Japan)

    Objective: The purpose of this study was to clarify the relationship between sleep disorders and cognitive function in PD by overnight electroencephalogram (EEG) and sleep…
  • 2025 International Congress

    Subthalamic Deep Brain Stimulation Modulates Cognitive-Motor Integration in Parkinson’s Disease: Insights from a Dual-task fNIRS Study

    YQ. Zhang, JP. Li, Y. Liang (Beijing, China)

    Objective: To investigate the effects of STN-DBS on cognitive-motor dual-task performance in PD patients using an executive function-motor function dual-task paradigm combined with functional near-infrared…
  • 2025 International Congress

    Accuracy of the Tanner’s Questionnaire and the REM Sleep Behavior Disorder Single-Question Screen as Screening Tools for Parkinson’s Disease in a Brazilian Cohort

    G. Bolner, G. Magalhães Pereira, N. Medeiros Soares, C. Cenci Sangali, D. Dos Santos, T. de Carvalho, C. Mello Rieder, A. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: Assess the Tanner’s Questionnaire (TQ) and the REM Sleep Behavior Disorder Single-Question Screen (RBD1Q) performance as screening tools for Parkinson’s Disease (PD) in a…
  • 2025 International Congress

    Assessment of cognitive impairment in Parkinson’s disease in Bangladeshi patients in Dhaka as part of the London-Dhaka Parkinson’s Cognition Study

    A. Haque, K. Dey, T. Zannat, A. Zirra, E. Camboe, S. Waters, D. Mair, T. Haque, C. Marshall, R. Weil, N. Mukadam, A. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: This study aimed to evaluate the prevalence of CI in a diverse group of patients with PD in Dhaka, Bangladesh. This study also aimed…
  • 2025 International Congress

    Developing Disease-duration Specific Percentiles for Prospective Subtyping of the Diffuse Malignant Parkinson’s Disease: A PPMI-based study

    A. Negida, M. Barrett, SM. Fereshtehnejad, B. Berman, N. Mukhopadhyay (Toronto, Canada)

    Objective: To enable prospective identification of individuals with diffuse malignant (DM) Parkinson’s disease (PD) by establishing disease-duration-specific thresholds for motor and non-motor symptom scales. Background:…
  • 2025 International Congress

    Prodromal Parkinson’s Disease in Agent Orange Exposed US Vietnam Veterans

    E. Uc, C. Weber, M. Lenz, J. Dawson (Iowa City, USA)

    Objective: 1-Comparing the risk of prodromal PD between AO exposed veterans (AOEV) and non-AO exposed veterans without PD (Controls) in a Veterans Affairs (VA) hospital…
  • 2025 International Congress

    Multidisciplinary Approaches to Palliative Care in Late-Stage Parkinson’s Disease: A Review of Educational Tools and Frameworks

    M. Farghaly, H. Khabiry, O. Sabry, A. Nagah, O. Awadalla, M. Elsayed (Giza, Egypt)

    Objective: To evaluate multidisciplinary approaches to palliative care in late-stage Parkinson’s disease (PD) and assess the effectiveness of educational tools and frameworks in improving patient…
  • 2025 International Congress

    Family History of Parkinson’s Disease in Patients with Essential Tremor and in Patients with Parkinson’s Disease and Its Association with Different Phenotypes.

    R. Sanjinez, J. Bestoso (Buenos Aires, Argentina)

    Objective: To clinically and phenotypically describe essential tremor (ET) and parkinson's disease (PD) patients and compare their familial histories in first- and second-degree relatives.. Background:…
  • 2025 International Congress

    Risk factors in a population with high prevalence of Parkinson’s disease in Chile

    ME. Contreras Pinto, U. Hernandez Villarroel, N. Angel, F. Pancetti Vaccari, B. Soto, M. Ramirez, M. Vera Amoroso, J. Otero Olmos, G. Oneto Diaz, C. Morales (la serena, Chile)

    Objective: The aim of this study was to investigate the frequency of environmental risk factors, comorbidities and family history in a population with Pakinson disease…
  • 1
  • 2
  • 3
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley